1/ The wide range of predictions here is appropriate given how little we know about severity.

Many are pointing to the @imperialcollege @nfergus study as support for a belief that Omicron has similar severity than Delta.

I don't think it does.

Let's dig in
2/ the paper is here if you want to read it for yourself. imperial.ac.uk/media/imperial…

They looked at UK COVID cases with (n=208,947) and without (n=15,087) the dropout associated w Omicron, and perform regression analyses to see what factors could predict Omicron

Date, for one
3/ for example, to predict whether a case is Omicron, you could find a clue by whether they are a reinfection (breakthrough).

There were 4,100 reinfections, but 36% of them were in the dropout group, compared w only 7% of the total cases. (OR 6.55 after controlling for all else)
4/ there are lots of cases in the dataset, so you can include lots of variables in the regression.

But the number of hospitalized was low. Only 1,392 / 209,000 S+ cases ~ 0.7%

And the "Omicron" (S-) hospitalization rate was 24/15,087 ~ 0.15%

That's right. 24 cases total
5/ so the authors are correct in saying that whether a person got hospitalized is not useful for statistically predicting whether the case is Omicron or not, but that's mostly because there are so few hospitalized cases in the sample (and only 24 w Omicron).
6/ while raw percent showed 4x lower hosp rate among Omicron, after statistical accounting for multiple variables (eg Omicron cases more likely to be vaccinated), the rate of hospitalization between S+ and S- is essentially equivalent

But there are lots of entangled variables
7/ I would consider the Imperial study conclusion as

"we can't say if it's less severe or not"

Not

"Seems to be equivalent"

(I remain hopeful 🙏)
8/An example for caution on interpreting these multiple regression results w entangled variables, I don't actually believe that getting 2 doses of Pfizer is "NEGATIVELY protective" against Omicron, even if the statistical confidence limits don't include 1, and the p value is tiny
9/ key table is here

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Farzad Mostashari

Farzad Mostashari Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @Farzad_MD

17 Dec
1/ Omicron is ripping through America right now, to an extent we won't fully realize until later

At this point, I think most people can hope to delay infection, but not to avoid it.

I don't think herd immunity is a realistic goal anymore

Here's what I think it means for us
2/ Even as the Delta wave continues to kill over a thousand people a day, Omicron is already here, and there is no reason to believe that the explosive growth we have seen in other countries, and in local outbreak (like Cornell University) isn't happening across the US already.
3/ an Intrinsic infectiousness that is perhaps 2-3 times higher than Delta, with a short incubation time, and at least some measure of immune escape- means that we are unlikely to get Rt below 1 (and the outbreak quenched) before it rips through a large proportion of susceptibles
Read 17 tweets
23 Oct
1/ Let's do an exercise together:

We've often heard people say something like "this innovative new service/company is good for patients and saves money, but there's no business model for it/ current reimbursement doesn't support it"

Step 1: Let's generate examples:
2/ I'll start.

But this is a group exercise, I need your nominations. Please try to give suggestions with some evidence behind them

*Advanced Care Planning
*Hospital at home
*Diabetes prevention program
*"SDOH" care navigation

(Used to be, telehealth)
3/ great work, tweeple

Clearly no shortage of ideas (with varying level of evidence) for things that could save money and be good for patients

The view espoused by many (including yours truly) has been that these services will flourish under value-based care

But not that easy
Read 19 tweets
20 Oct
The @AledadeACO annual awards!

1) Service.

Team Award: The Pharmacy Team!!
2) Accountability.

Individual Award:
Stephanie Sydorko (Tech Lead, Engineering)

Team Award:
CA-ledade (which has rapidly become our largest MSSP market)
3) Inclusion

Individual Award
Supreme Ally Commander
Michael Jones

Team Award
Health Equity Team (led by @kishadavismd)
Read 6 tweets
6 Oct
1/ Private Equity Investment As A Divining Rod For Market Failure: Policy Responses To Harmful Physician Practice Acquisitions

This is an important, thoughtful piece.

HT @LorenAdler
2/ As the title implies, the best way to think about the problem is that Private Equity points the way towards every opportunity for outsized financial gains, especially where there is arbitrage, or market failures.

PE investors use the word "rents" in a positive way
3/ As @brianwpowers @WillShrank have pointed out, if you create outsized opportunities in new payment models, private capital can accelerated that too

Though IMO they undersell the degree to which PE-backed groups in MA tend to focus on...risk adjustment

Read 7 tweets
26 Sep
This is actually an answerable question.

Does case severity drop during times when there are lots of open hospital beds?

Seems like a good episode of @DrBapuPod @AnupamBJena
Can we measure "likely unnecessary admissions" somehow?
...and to be clear, I am not sympathetic to the idea that we should somehow minimize the terrible negative impact of covid on hospitals and ICUs being full
Read 4 tweets
15 Aug
1) Private Equity and Health Care Delivery by @brianwpowers @WillShrank @AmolNavathe

💯 Agree private equity isn't inherently good or bad "acts to amplify the response to extant financial incentives"

A couple of further points though....

ja.ma/3m6K6FU @JAMA_current
2) it's true that good policy can align private profit with public good, but if we are going to rely on that, need tight surveillance and fast response from regulators to close arbitrage opportunities where short-term profit maximizers will gather. c/f surprise billing
3/ if you wait too long, then entrenched profits become normalized, powerful incumbents are formed, and they can, and will, exert political influence to keep the "status quo" in place.

Many health policy examples (facility fees, drug pricing). But also...Medicare Advantage 👀
Read 12 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(